1-20 of 39
Jennifer L Crombie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characteristics and Outcomes of Patients with Double Refractory (DR) or Double Exposed (DE) CLL

James T. Yoon, Yinglu Zhou, Svitlana Tyekucheva, Mariia Mikhaleva, Stacey M. Fernandes, Philippe Armand, Amy C. Bessnow, Jennifer L. Crombie, David C. Fisher, Eric D. Jacobsen, Caron A. Jacobson, Austin I. Kim, Ann S. LaCasce, Reid W. Merryman, Oreofe O. Odejide, Erin M. Parry, David A. Qualls, Christine E. Ryan, Aswin Sekar, Jacob D. Soumerai, Jon E. Arnason, Matthew S. Davids, Jennifer R. Brown, Inhye E. Ahn
Journal: Blood
Blood (2024) 144 (Supplement 1): 4617.
https://doi.org/10.1182/blood-2024-199577
Published: 2024
Journal Articles

A Phase 2 Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Richter's Syndrome (RS)

Jennifer L. Crombie, Christine E. Ryan, Yue Ren, Svitlana Tyekucheva, Celeste Carey, Aaron Zou, Samantha Normilus, Josie Montegaard, Jacob D. Soumerai, Shruti Bhandari, Jon E. Arnason, Alvaro J Alencar, Austin I. Kim, Erin M. Parry, Philippe Armand, David C. Fisher, Jennifer R. Brown, Matthew S. Davids
Journal: Blood
Blood (2024) 144 (Supplement 1): 4628.
https://doi.org/10.1182/blood-2024-199234
Published: 2024
Journal Articles

Long-Term Follow-up of Bendamustine/Rituximab - Rituximab/Cytarabine (BR/RC) Induction Therapy for Previously Untreated Transplant-Eligible Patients with Mantle Cell Lymphoma (MCL)

Christine E. Ryan, Imran A. Nizamuddin, Hari S. Raman, Robert A. Redd, Marcus P. Watkins, Ann S. LaCasce, David C. Fisher, Austin I. Kim, Matthew S. Davids, Caron A. Jacobson, Oreofe O. Odejide, Jennifer L. Crombie, Neha Mehta-Shah, Amanda F. Cashen, Armin Ghobadi, Nancy L. Bartlett, Eric D. Jacobsen, Philippe Armand, Brad S. Kahl, Reid W. Merryman
Journal: Blood
Blood (2024) 144 (Supplement 1): 4409.
https://doi.org/10.1182/blood-2024-198687
Published: 2024
Journal Articles

Preliminary Efficacy and Safety of a Phase 1/2 Study of Acalabrutinib, Venetoclax, and Obinutuzumab in Patients with Relapsed/Refractory and Previously Untreated Mantle Cell Lymphoma (MAVO)

Austin I. Kim, Philippe Armand, Christine E. Ryan, Robert A. Redd, Megan Forsyth, Juniper Mai, Samantha Pazienza, Caitlin Bresnahan, Vanessa M Kats, Salah Abdulkarim, Susan M Waisgerber, Reid W. Merryman, David C. Fisher, Inhye E. Ahn, Jennifer L. Crombie, Oreofe O. Odejide, Ann S. LaCasce, Caron A. Jacobson, Eric D. Jacobsen, Erin M. Parry, David A. Qualls, Amy C. Bessnow, Matthew S. Davids, Jennifer R. Brown, Jon E. Arnason, Michael Leukam, Peter A. Riedell, Mark A. Murakami
Journal: Blood
Blood (2024) 144 (Supplement 1): 4408.
https://doi.org/10.1182/blood-2024-198056
Published: 2024
Journal Articles

Allogeneic Stem Cell Transplantation As Consolidation Therapy in Patients with Relapsed-Refractory B-Cell Lymphoma Exposed to Bispecific Antibodies: A Study on Behalf of Grupo Español De Transplante y Terapia Celular (GETH-TC)

Marta Peña, Giulia Losi, Marco Aurelio Salvino, David A. Qualls, Jennifer L. Crombie, Jacopo Mariotti, Stefania Bramanti, Nicole Fabbri, Angel Serna, Yasmina I.M. Serroukh, Aitana Balaguer Rosello, Marjolein W.M. van der Poel, Ya Ting Hsu, Ana Jiménez Ubieto, Christopher McKinnely, Blanca Rius-Sansalvador, Felipe Peña, Lucia Lopez Corral, Carlos Panizo, Jose Antonio Pérez-Simón, Montserrat Rovira, Sebastián Garzón, Mi Kwon, David Valcarcel, Rosario Varela, Jaime Sanz, Andres Sanchez Salinas, Manuel Jurado, Maria Calbacho, Carmen Albo Lopez, Maria Del Mar Perera Alvarez, Inmaculada Heras, Leyre Bento De Miguel, Philippe Armand, Anna Sureda Balari, Alberto Mussetti
Journal: Blood
Blood (2024) 144 (Supplement 1): 3565.
https://doi.org/10.1182/blood-2024-201944
Published: 2024
Journal Articles

Efficacy and Safety of Odronextamab Monotherapy in Patients (Pts) with Diffuse Large B-Cell Lymphoma (DLBCL) Progressing after CAR T-Cell Therapy: Primary Analysis from the ELM-1 Study

Matthew Matasar, Max S. Topp, John N. Allan, Stephen M. Ansell, Jeffrey A. Barnes, Jon E. Arnason, Jean-Marie Michot, Neta Goldschmidt, Susan M. O'Brien, Uri Abadi, Irit Avivi Mazza, Jingxian Cai, Julia Zecchini, Min Zhu, Jurriaan Brouwer-Visser, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Jennifer L. Crombie
Journal: Blood
Blood (2024) 144 (Supplement 1): 866.
https://doi.org/10.1182/blood-2024-199155
Published: 2024
Journal Articles

Primary Endpoint Evaluation of a Multicenter, Phase 2 Study of Acalabrutinib, Venetoclax, Obinutuzumab (AVO) in a Population of Previously Untreated Patients with CLL Enriched for High-Risk Disease

Matthew S. Davids, Christine E. Ryan, Yue Ren, Liam Hackett, Jeremy Zhang, Svitlana Tyekucheva, Stacey M. Fernandes, Jennifer L. Crombie, Austin I. Kim, Matthew Weinstock, Josie Montegaard, Heather A. Walker, Claire Greenman, Victoria Patterson, Caron A. Jacobson, Ann S. LaCasce, Philippe Armand, David C. Fisher, Steve Lo, Adam J. Olszewski, Jon E. Arnason, Inhye E. Ahn, Jennifer R. Brown
Journal: Blood
Blood (2024) 144 (Supplement 1): 1865.
https://doi.org/10.1182/blood-2024-206556
Published: 2024
Journal Articles

Ipilimumab with and without Nivolumab in Patients with Classic Hodgkin Lymphoma with Progression after PD-1 Blockade

Reid W. Merryman, Justin Kline, Robert A. Redd, Emma L. Welsh, Kathleen Pfaff, Hannah Juhaie Lee, Mikaela M. McDonough, Inhye E. Ahn, Jennifer R. Brown, Jennifer L. Crombie, Matthew S. Davids, David C. Fisher, Eric D. Jacobsen, Caron A. Jacobson, Austin I. Kim, Oreofe O. Odejide, Erin M. Parry, Christine E. Ryan, Margaret A. Shipp, Philippe Armand, Scott J. Rodig, Jeremy S. Abramson, Ann S. LaCasce
Journal: Blood
Blood (2024) 144 (Supplement 1): 1669.
https://doi.org/10.1182/blood-2024-203414
Published: 2024
Journal Articles

Real-World (RW) Outcomes of Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL) and Secondary Central Nervous System (sCNS) Involvement from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

Sairah Ahmed, Avyakta Kallam, Matthew Frigault, Bradley D. Hunter, Sagar S. Patel, David Bernasconi, Soyoung Kim, Tracy Krimmel, Fei Fei Liu, Debasmita Roy, Marcelo C. Pasquini, Jennifer L. Crombie
Journal: Blood
Blood (2024) 144 (Supplement 1): 472.
https://doi.org/10.1182/blood-2024-199702
Published: 2024
Journal Articles

Real-World (RW) Outcomes of Lisocabtagene Maraleucel (liso-cel) As Second-Line (2L) Therapy in Patients (pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): First Results from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

Maria Silvina Odstrcil Bobillo, Swetha Kambhampati, Dasom Lee, Bradley D. Hunter, Ogechukwu Egini, Krish Patel, Patrick M. Reagan, David Bernasconi, Soyoung Kim, Charimar Santiago Parrilla, Tracy Krimmel, Fei Fei Liu, Debasmita Roy, Sairah Ahmed, Jennifer L. Crombie, Saurabh Dahiya, Mehdi Hamadani, Catherine J. Lee, Marcelo C. Pasquini, Mazyar Shadman, Alex F. Herrera, Matthew Frigault
Journal: Blood
Blood (2024) 144 (Supplement 1): 470.
https://doi.org/10.1182/blood-2024-199723
Published: 2024
Journal Articles

Long-Term Efficacy and Safety of Odronextamab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Pooled Analysis from the ELM-1 and ELM-2 Studies

John N. Allan, Jennifer L. Crombie, Matthew Matasar, Max S. Topp, Jan Walewski, Tae Min Kim, Won-Seog Kim, Yuan Cheng, Dina Flink, Bertha Fearon Chalet, Hesham Mohamed, Srikanth Ambati, Aafia Chaudhry, Jon E. Arnason
Journal: Blood
Blood (2024) 144 (Supplement 1): 3118.
https://doi.org/10.1182/blood-2024-199980
Published: 2024
Journal Articles

Effect of Consolidation with Allogeneic Hematopoietic Cell Transplant Versus No Consolidation in Patients with Non-Hodgkin Lymphomas Treated with Bispecific Antibodies

Giulia Losi, Marta Peña, David A. Qualls, Jennifer L. Crombie, Jacopo Mariotti, Stefania Bramanti, Nicole Fabbri, Angel Serna, Yasmina I.M. Serroukh, Aitana Balaguer Rosello, Marjolein W.M. van der Poel, Ya-Ting Hsu, Ana Jiménez Ubieto, Christopher McKinnely, Philippe Armand, Felipe Peña, Itziar Carro, Carolina Martinez, Eva Domingo Domenech, Patricia Lopez Pereira, Carolina Esther Arevalo Leon, Eva Gonzalez Barca, Anna Sureda Balari, Alberto Mussetti
Journal: Blood
Blood (2024) 144 (Supplement 1): 4947.
https://doi.org/10.1182/blood-2024-202933
Published: 2024
Journal Articles

Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy

Jennifer L. Crombie, Tara Graff, Lorenzo Falchi, Yasmin H. Karimi, Rajat Bannerji, Loretta Nastoupil, Catherine Thieblemont, Renata Ursu, Nancy Bartlett, Victoria Nachar, Jonathan Weiss, Jane Osterson, Krish Patel, Joshua Brody, Jeremy S. Abramson, Matthew Lunning, Nirav N. Shah, Ayed Ayed, Manali Kamdar, Benjamin Parsons, Paolo Caimi, Ian Flinn, Alex Herrera, Jeffrey Sharman, Marshall McKenna, Philippe Armand, Brad Kahl, Sonali Smith, Andrew Zelenetz, Lihua Elizabeth Budde, Martin Hutchings, Tycel Phillips, Michael Dickinson
Journal: Blood
Blood (2024) 143 (16): 1565–1575.
https://doi.org/10.1182/blood.2023022432
Published: 2024
Journal Articles

Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study

Clinical Trials & Observations
David A. Qualls, Nicholas Lambert, Paolo F. Caimi, Mwanasha Merrill, Priyanka Pullarkat, Richard C. Godby, David A. Bond, Graham T. Wehmeyer, Jason Romancik, Behzad Amoozgar, Lori Leslie, Loretta J. Nastoupil, Jennifer L. Crombie, Jeremy S. Abramson, Arushi Khurana, Grzegorz S. Nowakowski, Kami Maddocks, Sarah C. Rutherford, Brad Kahl, Michelle Okwali, Michael J. Buege, Venkatraman Seshan, Connie L. Batlevi, Gilles Salles
Journal: Blood
Blood (2023) 142 (26): 2327–2331.
https://doi.org/10.1182/blood.2023021274
Published: 2023
Includes: Supplemental data
Journal Articles

A Phase 2 Study of Acalabrutinib, Umbralisib, and Ublituximab (AU2) in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Inhye E Ahn, Yinglu Zhou, Svitlana Tyekucheva, Hannah Cormier, Stacey M Fernandes, Josie Montegaard, Marykate Kilcommons, Jennifer L Crombie, Reid W. Merryman, Erin M Parry, Philippe Armand, David C Fisher, Caron A Jacobson, Matthew S Davids, Jennifer R. Brown
Journal: Blood
Blood (2023) 142 (Supplement 1): 1914.
https://doi.org/10.1182/blood-2023-180788
Published: 2023
Journal Articles

Odronextamab Demonstrates Durable Complete Responses in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Progressing after CAR-T Therapy: Outcomes from the ELM-1 Study

Jennifer L. Crombie, Matthew Matasar, Max S. Topp, John N. Allan, Jeffrey A. Barnes, Jon E. Arnason, Jean-Marie Michot, Neta Goldschmidt, Susan M. O'Brien, Uri Abadi, Irit Avivi Mazza, Jessica Cai, Dina M. Flink, Min Zhu, Jurriaan Brouwer-Visser, Hesham Mohamed, Aafia Chaudhry, Srikanth Ambati, Steve M Ansell
Journal: Blood
Blood (2023) 142 (Supplement 1): 4461.
https://doi.org/10.1182/blood-2023-181602
Published: 2023
Journal Articles

Phase I Safety and Preliminary Efficacy of Acalabrutinib, Venetoclax, and Obinutuzumab (AVO) in Patients with Relapsed/Refractory Mantle Cell Lymphoma

Austin I Kim, Philippe Armand, Robert A. Redd, Megan Forsyth, Paul Branch, Samantha Pazienza, Lisa Brennan, Victoria Patterson, Susan M Waisgerber, Reid W. Merryman, David C Fisher, Christine E. Ryan, Inhye E Ahn, Jennifer L Crombie, Oreofe O. Odejide, Ann LaCasce, Caron A Jacobson, Eric Jacobsen, Erin M Parry, Matthew S Davids, Jennifer R. Brown, Arnold S. Freedman, Peter A. Riedell, Mark Alan Murakami
Journal: Blood
Blood (2023) 142 (Supplement 1): 3031.
https://doi.org/10.1182/blood-2023-173103
Published: 2023
Journal Articles

Loncastuximab in High-Risk and Heavily-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real World Analysis from 21 US Centers

Emily Ayers, Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha, Ning Dong, David Augustus Qualls, Behzad Amoozgar, Brad S. Kahl, John H. Baird, Pavan Challa, Scott F. Huntington, Jennifer Santos, Steven M. Bair, Mayur S. Narkhede, Shuning Li, Zachary AK Frosch, Carrie I Ho, Stephen D Smith, Allison Winter, Daniel J. Landsburg, Fateeha Furqan, Mehdi Hamadani, Katelin Baird, Jason T. Romancik, Hanan Alharthy, Jennie Law, Leyla Bojanini, Ranjana H. Advani, Boyu Hu, Patrick Connor Johnson, Natalie S. Grover, Debamita Kundu, Mwanasha Hamuza Merrill, Jennifer L Crombie, Nazila Shafagati, Cole Sterling, Loretta J. Nastoupil, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 312.
https://doi.org/10.1182/blood-2023-174257
Published: 2023
Journal Articles

A Phase I Study of Copanlisib and Venetoclax in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Jennifer L Crombie, Austin I Kim, Nancy L. Bartlett, Robert A. Redd, Victoria Patterson, Celeste Carey, Sobana Balasubramanian, Oreofe O. Odejide, Reid W. Merryman, Ann LaCasce, Caron A Jacobson, Eric Jacobsen, Erin M Parry, David C Fisher, Alex F. Herrera, Matthew S Davids, Margaret A. Shipp, Philippe Armand, Geoffrey P. Shouse
Journal: Blood
Blood (2023) 142 (Supplement 1): 1735.
https://doi.org/10.1182/blood-2023-181067
Published: 2023
Journal Articles

Outcomes of Sequential CD19-Directed Therapies in Relapsed and Refractory Large B Cell Lymphoma

David A Qualls, Nicholas Lambert, Paolo F. Caimi, Mwanasha Hamuza Merrill, Priyanka Pullarkat, Richard C. Godby, David A. Bond, Graham Wehmeyer, Jason T. Romancik, Behzad Amoozgar, Lori A. Leslie, Loretta J. Nastoupil, Jennifer L Crombie, Jeremy S. Abramson, Arushi Khurana, Grzegorz S. Nowakowski, Kami J. Maddocks, Sarah C. Rutherford, Brad S. Kahl, Michelle Okwali, Michael Buege, Venkatraman Seshan, Connie Wing-Ching Lee Batlevi, Gilles Salles
Journal: Blood
Blood (2023) 142 (Supplement 1): 3136.
https://doi.org/10.1182/blood-2023-182204
Published: 2023